Cholesterol and its metabolites are reduced at sites of inflammatory demyelination, and the expression of CYP46A1, a key enzyme in maintaining cholesterol homeostasis, was reduced in the MS GM. The gene discussed is CYP46A1; the disease is myeloid sarcoma.